Deep search
Profile Picture
  • All
  • Search
  • Copilot
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

mifepristone, FDA and abortion pill

CBS News on MSN · 1d
FDA to "review the latest data" on mifepristone. What could it mean for access to the abortion pill?
HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns about the abortion pill's safety are misguided.
U.S. News & World Report · 1d
RFK Jr. Calls for a Review of Abortion Pill Mifepristone
THURSDAY, June 5, 2025 (HealthDay News) — U.S. Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a fresh safety review of mifepristone, a drug commonly used in medication abortions.
Los Angeles Times on MSN · 1d
California petitions FDA to undo RFK Jr.'s new limits on abortion pill mifepristone
California and three other states have called on the FDA to ease new restrictions on the abortion pill mifepristone, which they say has a strong safety record.
STAT
15h
Pharmalittle: We’re reading about GLP-1 drugs and eye disease, European pharma reforms, and more
HHS Secretary Robert F. Kennedy Jr. said that the FDA would look for ways to fast-track approval for rare disease treatments ...
Opinion
10don MSNOpinion
A Convenient Piece of Junk Science
RFK Jr. is prepared to rework the FDA’s official assessment of the abortion pill mifepristone based at least in part on a questionable report.
3d
FDA chief vows mifepristone probe
The Food and Drug Administration commissioner has committed to reviewing the abortion drug mifepristone after previously ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy